The Keith Campbell Foundation For the Environment, Inc

The Myles D. and J. Faye Sampson Family Foundation, located in Bethesda, MD, focuses on intentional philanthropy with an emphasis on education. The foundation currently operates a grant application process that is by invitation only, ensuring a targeted approach to funding. Under the leadership of Executive Director Rebecka Manglanathan, along with Senior Advisor Holli B. Rivera and Grants Manager Vanessa Rivera, the foundation aims to support impactful initiatives aligned with its mission. The organization values a collaborative and participatory approach to grantmaking, fostering meaningful relationships with its grantees. Generated from the website

Ahr Second Borrower LLC is a financial services company based in Bethesda, MD, specializing in providing lending solutions to individuals and businesses. With a focus on second borrowing options, the company offers a range of customized loan products to suit various financial needs. Committed to delivering personalized and efficient services, Ahr Second Borrower LLC strives to assist clients in achieving their financial goals through flexible and transparent lending practices. The company's experienced team works closely with customers to find the best borrowing solutions tailored to their unique circumstances. Generated from their business information

Northwest Biotherapeutics is a biotechnology company that focuses on the clinical development of autologous immunotherapy products for cancer. The company s technology platform, DCVax, uses a patient s own dendritic cells. These cells are the starter engines of the immune system, which are loaded with tumor proteins or antigens. Injection of dendritic cells back into the patient initiates a potent immune response against cancer cells, resulting in delayed time to progression and prolonged survival. The company s two lead product candidates, DCVax-Prostate and DCVax-Brain, are in Food & Drug Administration-allowed late stage clinical trials, from which licensure is possible. Related products in the company s pipeline are also ready to enter Phase I clinical trials. Northwest Biotherapeutics is located in Bothell, Wash.